These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1726720)

  • 1. [Quantitative analyses of human prostatic alpha-adrenoceptors and effects of terazosin on the alpha-adrenoceptor activity].
    Morita T
    J Smooth Muscle Res; 1991 Jun; 27(3):149-54. PubMed ID: 1726720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].
    Morita T; Kondo S
    Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):334-7. PubMed ID: 1373456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia.
    Lepor H; Gup DI; Baumann M; Shapiro E
    Urology; 1988 Dec; 32(6 Suppl):21-6. PubMed ID: 2462301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dicentrine, a novel alpha 1-adrenoceptor antagonist, on human hyperplastic prostates.
    Yu SM; Ko FN; Chueh SC; Chen J; Chen SC; Chen CC; Teng CM
    Eur J Pharmacol; 1994 Jan; 252(1):29-34. PubMed ID: 7512043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain.
    Lepor H; Baumann M; Shapiro E
    J Urol; 1988 Sep; 140(3):664-7. PubMed ID: 2457715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and functional properties of doxazosin in the human prostate adenoma and canine brain.
    Lepor H; Baumann M; Shapiro E
    Prostate; 1990; 16(1):29-38. PubMed ID: 1968249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Density and localization of alpha 1-adrenoceptors in hypertrophied prostate.
    Kawabe K; Moriyama N; Hamada K; Ishima T
    J Urol; 1990 Mar; 143(3):592-5. PubMed ID: 1689399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy.
    Yamada S; Suzuki M; Kato Y; Kimura R; Mori R; Matsumoto K; Maruyama M; Kawabe K
    Life Sci; 1992; 50(2):127-35. PubMed ID: 1370569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N; Benning CM
    Cancer Res; 2000 Aug; 60(16):4550-5. PubMed ID: 10969806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK; Blaylock NA; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate.
    Michel MC; Grübbel B; Taguchi K; Verfürth F; Otto T; Kröpfl D
    J Auton Pharmacol; 1996 Feb; 16(1):21-8. PubMed ID: 8736427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy.
    Yamada S; Ashizawa N; Ushijima H; Nakayama K; Hayashi E; Honda K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):326-30. PubMed ID: 2441028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of the alpha-adrenoceptors in human prostate.
    Hieble JP; Caine M; Zalaznik E
    Eur J Pharmacol; 1985 Jan; 107(2):111-7. PubMed ID: 2579826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.
    Amadesi S; Varani K; Spisani L; Daniele C; Turini A; Agnello G; Zamboni P; Borea PA; Geppetti P
    Prostate; 2001 Jun; 47(4):231-8. PubMed ID: 11398170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
    Seo KK; Lee MY; Lim SW; Kim SC
    J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
    Tsuchihashi H; Nagatomo T
    J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]bunazosin, a novel selective radioligand of alpha 1 adrenoceptors in human prostates.
    Yamada S; Suzuki M; Matsuoka Y; Kato Y; Kimura R; Maruyama M; Kawabe K
    J Urol; 1991 Sep; 146(3):877-80. PubMed ID: 1714973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.